Valuation: Arcoma AB

Market Cap 12Cr 1.19Cr 1.04Cr 97.06L 89.23L 1.68Cr 114.11Cr 1.72Cr 4.5Cr 57Cr 4.48Cr 4.38Cr 196.45Cr P/E 2024
12.7x
P/E 2025 20.9x
Enterprise Value 7.98Cr 82.8L 72.16L 67.34L 61.9L 1.16Cr 79Cr 1.19Cr 3.12Cr 39Cr 3.11Cr 3.04Cr 136.29Cr EV / Sales 2024
0.82x
EV / Sales 2025 0.53x
Free-Float
52.21%
Yield 2024 *
-
Yield 2025 -
1 day+0.25%
1 week-4.74%
Current month-9.87%
1 month-8.64%
3 months+8.06%
6 months+7.77%
Current year+9.54%
1 week 7.96
Extreme 7.96
8.4
1 month 7.02
Extreme 7.02
8.96
Current year 6.16
Extreme 6.16
10.05
1 year 6.16
Extreme 6.16
11
3 years 6.16
Extreme 6.16
18.3
5 years 6.16
Extreme 6.16
20.2
10 years 3.57
Extreme 3.57
26.3
Manager TitleAgeSince
Chief Executive Officer 45 01/01/2023
Director of Finance/CFO 42 01/01/2022
Chief Tech/Sci/R&D Officer - 01/06/2026
Director TitleAgeSince
Director/Board Member 55 01/01/2012
Chairman 54 01/01/2017
Director/Board Member 59 01/01/2022
Change 5-day change 1-year change 3-year change Capi.($)
+0.25%-4.74%-20.79%-10.17% 1.18Cr
+2.70%-0.47%-17.23%-21.68% 1.34TCr
+0.07%-8.14%+39.48%-12.31% 398.82Cr
-0.60%-0.75%+65.05%+114.72% 121.22Cr
+1.46%+2.25%-39.18%-59.33% 120.7Cr
+2.46%+3.43%-38.94%-47.00% 110Cr
+2.86%-2.96%-45.13% - 91Cr
-0.61%-1.93%+25.62%+80.83% 47Cr
+0.15%-5.56%+52.41% - 33Cr
-2.71%-10.44%-62.26%+196.20% 25Cr
Average +0.60%-1.85%-4.10%+30.16% 229.21Cr
Weighted average by Cap. +1.83%-0.64%-4.92%-10.98%

Financials

2024 2025
Net sales 16Cr 1.63Cr 1.42Cr 1.32Cr 1.22Cr 2.28Cr 155.54Cr 2.34Cr 6.13Cr 77Cr 6.11Cr 5.97Cr 267.77Cr 13Cr 1.36Cr 1.18Cr 1.1Cr 1.01Cr 1.9Cr 129.74Cr 1.95Cr 5.11Cr 64Cr 5.09Cr 4.98Cr 223.36Cr
Net income 1.12Cr 11.6L 10.11L 9L 9L 16.28L 11Cr 16.68L 43.7L 5.51Cr 43.53L 42.58L 19Cr 50.3L 5L 5L 4L 4L 7L 4.99Cr 8L 19.66L 2.48Cr 19.59L 19.16L 8.59Cr
Net Debt -1.33Cr -13.81L -12.04L -11.24L -10.33L -19.39L -13Cr -19.87L -52.06L -6.56Cr -51.85L -50.73L -23Cr -3.52Cr -36.54L -31.85L -29.72L -27.32L -51.3L -35Cr -52.57L -1.38Cr -17Cr -1.37Cr -1.34Cr -60Cr
Logo Arcoma AB
Arcoma AB is a Sweden-based medical technology company. It develops, produces and markets digital radiographic systems. Its products offer digital imaging technology combined with advanced mobile positioning system. The Company's product portfolio comprises: complete radiographic systems available as ceiling suspensions and floor mounted systems, as well as detectors; radiographic system components, such as overhead tube crane, cube, tilting wall stand and radiographic tables; and mobile imaging tables in two series, namely Precision and Elite. Its products are designed for hospitals, clinics, imaging centers and private practices, and available through three market channels: its own brand IMIX, private label distributors and original equipment manufacturers (OEM).
Employees
31
Date Price Change Volume
29/26/29 SEK 8.040 +0.25% 2,500
28/26/28 SEK 8.020 -3.14% 16,684
27/26/27 SEK 8.280 -0.72% 1,910
24/26/24 SEK 8.340 +3.99% 146
23/26/23 SEK 8.020 +0.75% 1,020

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ARCOMA Stock